LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

COHANCE

NSEBSE
Cohance Lifesciences Limited
Healthcare· Pharmaceuticals & Biotechnology· INE03QK01018· Scrip: 543064
ENहिन्दीગુજરાતીमराठी
४८७.९०
3.05 (+0.63%)
8/5/2026, 3:29:51 pm
NSE
४८७.९०
३.०५
+०.६३%
BSE
४८८.३०
३.४०
+०.००%
2794876969051,11405-1907-1109-0811-0412-3102-2605-0505-08
२३८ व्यापार दिन · 1Y कालावधी
आज
उघडणे४८४.८५
उच्चांक५०२.३५
नीचांक४८१.००
मागील बंद४८४.८५
व्हॉल्यूम२३.२७L
मूल्य₹११४.५Cr
L: 481.00H: 502.35
52 आठवडे
नीचांक२६६.७०
उच्चांक१,१५८.३०
२५% 52 आठवड्यांच्या श्रेणीत
माहिती
दर्शनी मूल्य₹१
सूचीबद्ध2020-03-09
ISININE03QK01018
SeriesA
BSE स्क्रिप543064

मुख्य निर्देशक

1D
+0.63%
1W
+0.96%
1M
+62.34%
3M
+27.89%
6M
-42.63%
मूल्यांकन
P/E (TTM)४४.४४
P/E (Qtr Ann.)३७.४२
P/Sales११.१५
वाढ (तिमाही)
PAT+1.60%
EPS+0.93%
नफाक्षमता
TTM EBITDA M.४१.१%
लाभांश
वाढ+400.00%

तिमाही वित्तीय

महसूल
EBITDA
PAT
EPS
0 Cr92 Cr185 Cr277 Cr369 Cr23-0323-0623-0923-1224-0324-0624-0924-124.94.73.11.82.12.43.23.3
तिमाहीमहसूलExpensesEBITDAPBTPATEPS
2024-12-31307 Cr213 Cr130 Cr110 Cr83 Cr3.26
2024-09-30258 Cr172 Cr116 Cr100 Cr82 Cr3.23
2024-06-30231 Cr166 Cr96 Cr83 Cr61 Cr2.39
2024-03-31253 Cr199 Cr88 Cr71 Cr53 Cr2.10
2023-12-31220 Cr169 Cr78 Cr65 Cr47 Cr1.84
2023-09-30231 Cr145 Cr117 Cr105 Cr80 Cr3.13
2023-06-30348 Cr194 Cr176 Cr164 Cr121 Cr4.74
2023-03-31369 Cr215 Cr178 Cr166 Cr124 Cr4.87

शेअरहोल्डिंग नमुना

सध्याचे2026-03-31
57.5%प्रवर्तक
प्रवर्तक57.5%
FII5.6%
DII21.8%
सार्वजनिक42.5%
सरकार0.0%
प्रवर्तक होल्डिंग ट्रेंड
50.1%24-0950.1%24-1250.1%25-0366.4%25-0557.5%25-0957.5%25-1257.5%26-03

कॉर्पोरेट कार्यवाही

एक्स-तारीखप्रकारउद्देश
2024-08-06OtherAnnual General Meeting
2023-12-12OtherAnnual General Meeting
2022-09-09DividendInterim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share
2022-08-11OtherAnnual General Meeting
2022-05-13DividendInterim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share
2022-02-15DividendInterim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share
2021-08-13Dividend Annual General Meeting/Dividend - Re 1 Per Share
2021-02-17Dividend Interim Dividend - Re 1 Per Share
2020-09-25Bonus Bonus 1:1

उत्पन्न विवरण

Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
12 Nov 2025NSE47K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Schedule of the results conference call
5 Nov 2025NSE3K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
13 Aug 2025NSE36K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
28 May 2025NSE45K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
12 Feb 2025NSE56K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
29 Feb 2024NSE40K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
24 Nov 2023NSE28K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE22K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
15 Nov 2022NSE39K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
16 Aug 2022NSE36K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Aug 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
8 Jun 2022NSE77K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
13 May 2022NSE41K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Revised Investor Presentation
9 May 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 May 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Feb 2022NSE9K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
6 Nov 2021NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
16 Aug 2021NSE7K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Jun 2021NSE7K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
11 Feb 2021NSE8K chars
Read →

किंमत इतिहास

तारीखउघडणेउच्चांकनीचांकबंदव्हॉल्यूम
2026-05-08४८४.८५५०२.३५४८१.००४८८.२०२३.३८L
2026-05-07४८६.५०४९४.२०४७८.५५४८४.८५१९.१७L
2026-05-06४५९.००४९९.००४५९.००४८१.२५१.४२Cr
2026-05-05४६७.८५४६७.८५४५०.८०४५४.१५१४.३७L
2026-05-04४८७.००४९०.००४६५.५०४७०.७५१८.७९L
2026-04-30४६९.७०४९८.८०४४२.६०४८३.२५१.२५Cr
2026-04-29४९४.८५५०६.००४६०.१०४६७.५५६८.७३L
2026-04-28४४४.४५५१४.९०४४४.००४९३.३०४.०९Cr
2026-04-27३८०.३५४३२.१०३७९.००४३२.१०१.३९Cr
2026-04-24३६५.६५३६९.८०३५५.०५३६०.१०९.०१L
2026-04-23३६४.४५३७४.८५३६०.५०३६३.९०१८.३५L
2026-04-22३६४.००३७२.९०३६०.३५३६२.९०१४.५५L
2026-04-21३६९.२०३७०.८०३५९.२५३६१.२०१९.०७L
2026-04-20३८८.००३८८.००३६७.००३६९.२०३२.०८L
2026-04-17३६२.९५४०६.५०३५९.५०३९०.५५१.३५Cr
2026-04-16३६०.००३६५.६५३५४.४५३६२.९५१३.८७L
2026-04-15३६४.००३६७.७०३५०.१०३५६.४०३८.१०L
2026-04-13३६४.८०३७०.६०३५३.१५३५८.६०७१.१२L
2026-04-10३२१.६०३८०.२०३१८.९०३७७.९०४.७६Cr
2026-04-09३०९.४५३२५.००३०६.००३१६.८५१३.८८L
2026-04-08३११.००३११.९५३००.४०३०९.५०८.९२L
2026-04-07३०२.९०३०६.९५२९६.७५३००.५५३.००L
2026-04-02३०९.६०३०९.६५३००.३०३०७.२५२.८०L
2026-04-01३०८.९५३१७.५०३०४.००३११.९५४.९८L
2026-03-27३०५.००३०९.००२९६.२०३०२.७०१०.२६L
2026-03-25२९७.५०३१२.१५२९७.४०३०६.१५६.४५L
2026-03-24३०७.८५३०७.८५२९३.००२९६.३०५.२३L
2026-03-20३०४.२५३०४.२५२९६.०५२९९.२५५.१५L
2026-03-19३०१.५५३०४.२०२९५.५०२९९.२५३.३४L
2026-03-18३०४.३०३०९.७५३००.४५३०६.२५५.२२L

वारंवार विचारले जाणारे प्रश्न

बद्दल

Cohance Lifesciences Limited, पूर्वी सुवेन फार्मास्युटिकल्स म्हणून ओळखली जात होती, ही भारत-आधारित कॉन्ट्रॅक्ट डेव्हलपमेंट आणि मॅन्युफॅक्चरिंग संस्था (CDMO) आहे जी एकात्मिक फार्मास्युटिकल सेवा देते. फॉर्म्युलेशन डेव्हलपमेंट, विश्लेषणात्मक सेवा आणि व्यावसायिक उत्पादनासह औषध विकास आणि उत्पादनासाठी तंत्रज्ञान-आधारित उपाय प्रदान करण्यात कंपनी माहिर आहे.

Advertisement
BOARD OF DIRECTORS